Reading Time: 7 minutesIncreasing our understanding of MND, improving care and finding new potential treatments for the disease relies upon very talented and dedicated scientists working in MND
Tag: MND
Reading Time: 6 minutesPlease note that this blog talks about sensitive topics such as death and tissue donation throughout. Researchers use many different tools to increase our understanding
Reading Time: 5 minutesBuilding relationships with key research institutes across the UK is vital in pushing research forward in the fight against MND. As of 31 December 2023,
Reading Time: 5 minutesDespite extensive research, the causes of MND remain largely unknown. Recent investigations have begun to shed light on the gut microbiome and whether it may
Reading Time: 7 minutesResearchers from the University of Aberdeen and the University of Edinburgh have developed a new tool that could help to detect signs of MND in
Reading Time: 4 minutesHello everyone. My name is Genevieve (Gen) and I have joined the Association as Philanthropy Information Officer. One of my roles is to communicate the
Reading Time: 5 minutesHi, I’m Ben, a researcher working at Sheffield University. I attended last year’s International Symposium on ALS/MND as one of the Symposium Communication Ambassadors and
Reading Time: 7 minutesHi, I’m Heather, a PhD student from King’s College London, and a Communications Ambassador for the 34th International Symposium on ALS/MND which was held in Basel last December. Over 1,300 attendees from around the world gathered to connect with researchers and people affected by MND and engage with the latest research presented in the platform presentation and poster sessions. In this blog post, I will be sharing several of my personal highlights of the symposium, which cover how differences in our genetic code can be explored to understand their effects on MND risk and progression.
Reading Time: 5 minutes"New drug reduces risk of death by 50%"
You may have seen this type of headline in news articles reporting on the outcome of clinical trials. Reading this headline can lead people to believe a potential drug is highly beneficial and has a real impact. However, it is important to delve a little deeper into the meaning of ‘risk of death’, the raw data behind it, and how it should be considered alongside other outcome measures of a trial to fully determine how effective a drug might be.
Reading Time: 4 minutesIn our brains, specific areas control the movement of different body parts (see image below). As we know, MND is a complex disease with a lot of variation between individuals who are affected. For example, symptoms may start in different body parts for different individuals. Understanding why this happens may help us predict the disease onset site or progression across the body in the future.